IDH1 mutation, histology, and treatment of tissue metabolites in diffuse glioma

IDH1 mutation, histology, and treatment of tissue metabolites in diffuse glioma

In this episode, Ghazaleh Tabatabai and colleagues discuss the landscape of tissue metabolites and corresponding transcripts in diffuse glioma assessed by NMR metabolomics and RNA sequencing.